BofA Upgrades Pharvaris: What Investors Need to Know
BofA upgrades Pharvaris to Neutral ($27 target). Unique oral drug for angioedema treatment, but current price assumes success of upcoming data.
NOTRELOAD AI
TaskUs Stays Public: Blackstone Buyout Deal Falls Through
TaskUs stockholders reject Blackstone's take-private proposal. The company will remain publicly traded on Nasdaq as TASK after failing to secure necessary votes.
David Ellison Seeks Private Equity Partners for Massive Warner Bros. Discovery Bid
Paramount Skydance's David Ellison is courting major private equity firms including Apollo Global Management for a potential $60 billion Warner Bros. Discovery acquisition as funding questions mount.
TopBuild Closes $1B SPI Acquisition After Regulatory Reset
TopBuild completes $1 billion acquisition of Specialty Products and Insulation under Trump administration after 2023 deal collapsed due to antitrust concerns. Part of broader building-products consolidation wave.
Critical Metals Secures Major U.S. Offtake Deal to Challenge China's Rare Earth Dominance
Critical Metals Corp signs 10-year agreement with REalloys to supply 15% of rare earth production from Greenland's Tanbreez Project, strengthening U.S. supply chain independence.
Rocket Lab Secures Major Deal to Launch Japanese Earth-Imaging Satellites
Rocket Lab signs multi-launch contract with iQPS to deploy commercial Earth-imaging satellites, bringing total missions to seven with launches starting 2026.